Wang Wei, Cao Jingyi, Yan Xiaoshen, Zhuang Yu, Qiao Fan, Ning Xiaoping, Yu Min, Shi Sheng, Yang Dicheng, Shen Feng, Lu Fanglin
Department of Cardiovascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Hongkou District, Shanghai, 200080, China.
Suzhou Hearthill Medical Technology Co., Ltd, Suzhou, Jiangsu, 215123, China.
Macromol Biosci. 2025 Jul;25(7):e2400606. doi: 10.1002/mabi.202400606. Epub 2025 Apr 18.
Polymeric heart valves (PHVs) present a promising alternative to mechanical and bio-prosthetic valves, addressing critical issues such as durability and calcification. This study investigates poly(styrene-block-ethylene/butylene-block-styrene) (SEBS) block copolymers for PHV applications, focusing on material characterization, valve fabrication, in vitro durability testing, and in vivo bio-compatibility evaluation. Mechanical tests, including thermogravimetric analysis (TGA), dynamic mechanical analysis (DMA), differential scanning calorimetry (DSC), and hydrodynamic performance analysis demonstrated that SEBS offers excellent thermal stability, flexibility, and fatigue resistance. Bio-compatibility assessments conducted per ISO 10993 standards revealed minimal cytotoxicity, hemolysis, and adverse immune responses. The hydrodynamic performance tests showed favorable hemodynamics, with low transvalvular pressure gradients and effective orifice areas within acceptable limits. In vivo trials on animal models confirmed that SEBS valves maintained competent valve function, without significant structural degeneration or calcification, over the 140-day study period. Mild regurgitation, observed in a subset of models, is attributed to anatomical variations and surgical technique. These results suggest that SEBS-based PHVs are a durable, biocompatible alternative to traditional heart valves and hold promise for overcoming limitations associated with current mechanical and bioprosthetic designs.
聚合物心脏瓣膜(PHV)是机械瓣膜和生物人工瓣膜的一种有前景的替代方案,可解决诸如耐久性和钙化等关键问题。本研究调查了用于PHV应用的聚(苯乙烯-嵌段-乙烯/丁烯-嵌段-苯乙烯)(SEBS)嵌段共聚物,重点在于材料表征、瓣膜制造、体外耐久性测试和体内生物相容性评估。包括热重分析(TGA)、动态力学分析(DMA)、差示扫描量热法(DSC)和流体动力学性能分析在内的力学测试表明,SEBS具有出色的热稳定性、柔韧性和抗疲劳性。按照ISO 10993标准进行的生物相容性评估显示,细胞毒性、溶血和不良免疫反应极小。流体动力学性能测试显示血流动力学良好,跨瓣膜压力梯度低,有效瓣口面积在可接受范围内。在动物模型上进行的体内试验证实,在140天的研究期内,SEBS瓣膜保持了良好的瓣膜功能,没有明显的结构退变或钙化。在一部分模型中观察到的轻度反流归因于解剖学变异和手术技术。这些结果表明,基于SEBS的PHV是传统心脏瓣膜的一种耐用、生物相容的替代方案,有望克服与当前机械和生物假体设计相关的局限性。